Tenth Circuit Opinion in PCMA v. Mulready
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
Ruling creates a split in the federal courts that could lead to the Supreme Court.
NACDS is calling on North Carolina lawmakers to continue to stand up for North Carolinians in the face of “pharmaceutical benefit manipulation” in all its forms.
New PREP Act amendment issued today reflects strong and consistent urging of NACDS.
Article published in Johns Hopkins’ peer-reviewed Health Security journal follows a compelling announcement by the Biden Administration that gives states a window for action.
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
NACDS celebrates the enactment of a Florida bill holding PBMs accountable, marking a major victory for patients.
NACDS’ Principles of PBM Reform include “stopping the undercutting of reform laws” – as part of a comprehensive effort to end “pharmaceutical benefit manipulation” that harms patients, employers, taxpayers, communities, and pharmacies.
Anticipated PREP Act amendment reflects strong and consistent urging of NACDS.
NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.